Second Read and Referred S Families, Seniors and Health Committee
Email me when SB 1795 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 1795. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill directs the state Medicaid program (MO HealthNet) to pay for biomarker testing when it has proven clinical utility, and it obligates private insurers, nonprofit plans, and HMOs that issue contracts after August 28 2026 to do the same. It also sets up an easy‑to‑use exception process and limits the need for multiple biopsies. The measure does not require coverage for screening tests.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 1795
3 free questions a day, no accountHistory
- Second Read and Referred S Families, Seniors and Health Committee
- S First Read
Sponsors
- Stephen Webber (D) · sponsor
- Webber, Stephen
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 1795 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 1795 freeOr ask your AI assistant about SB 1795 directly:
Add to Claude, ChatGPT or Cursor